Interacting Drugs |
Cabergoline vs Sibutramine |
Security Level |
|
Mechanism |
Sibutramine: May enhance the serotonergic effect of Ergot Derivatives. This may cause serotonin syndrome. |
Management |
Sibutramine should generally be avoided in patients receiving treatment with ergot derivatives due to a theoretical risk of serotonin syndrome. If the combination cannot be avoided, monitor patients for signs/symptoms of serotonin toxicity. |
Cabergoline vs Sibutramine
Post Review about Cabergoline vs Sibutramine Click here to cancel reply.
Other Interactions of Sibutramine
Cabergoline vs Sibutramine
Interacting Drugs |
Cabergoline vs Sibutramine |
Security Level |
|
Mechanism |
Sibutramine: May enhance the serotonergic effect of Serotonin Modulators. This may cause serotonin syndrome. |
Management |
Avoid combination |
No comments yet.
Post Review about Cabergoline vs Sibutramine Click here to cancel reply.
Other Interactions of Sibutramine
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.